Trademark: 86391305
Status Date
Monday, April 16, 2018
Filing Date
Wednesday, September 10, 2014
Published for Opposition
Tuesday, January 13, 2015
Abandoned Date
Monday, April 16, 2018
5 Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Iron chelating pharmaceutical preparations; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; ; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceuticals preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antimicrobial for inhibiting microbiological decomposition in pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
Color is not claimed as a feature of the mark.
Apr 16, 2018
Abandonment Notice Mailed - No Use Statement Filed
Apr 16, 2018
Abandonment - No Use Statement Filed
Jan 3, 2018
Assignment Of Ownership Not Updated Automatically
Sep 20, 2017
Notice Of Approval Of Extension Request E-Mailed
Sep 19, 2017
Extension 5 Granted
Sep 7, 2017
Extension 5 Filed
Sep 7, 2017
Teas Extension Received
Mar 8, 2017
Automatic Update Of Assignment Of Ownership
Mar 8, 2017
Notice Of Approval Of Extension Request E-Mailed
Mar 7, 2017
Extension 4 Granted
Mar 1, 2017
Extension 4 Filed
Mar 1, 2017
Teas Extension Received
Jan 30, 2017
Teas Change Of Correspondence Received
Sep 8, 2016
Notice Of Approval Of Extension Request E-Mailed
Sep 7, 2016
Extension 3 Granted
Aug 30, 2016
Extension 3 Filed
Aug 30, 2016
Teas Extension Received
Apr 15, 2016
Notice Of Approval Of Extension Request E-Mailed
Apr 14, 2016
Extension 2 Granted
Mar 9, 2016
Extension 2 Filed
Apr 11, 2016
Case Assigned To Intent To Use Paralegal
Mar 9, 2016
Teas Extension Received
Sep 11, 2015
Notice Of Approval Of Extension Request E-Mailed
Sep 9, 2015
Extension 1 Granted
Sep 9, 2015
Extension 1 Filed
Sep 9, 2015
Teas Extension Received
Mar 10, 2015
Noa E-Mailed - Sou Required From Applicant
Jan 16, 2015
Changes/Corrections After Pub Approval Entered
Jan 16, 2015
Assigned To Petition Staff
Jan 13, 2015
Official Gazette Publication Confirmation E-Mailed
Jan 13, 2015
Published For Opposition
Jan 5, 2015
Teas Post Publication Amendment Received
Dec 24, 2014
Notification Of Notice Of Publication E-Mailed
Dec 10, 2014
Law Office Publication Review Completed
Dec 10, 2014
Assigned To Lie
Nov 26, 2014
Approved For Pub - Principal Register
Nov 25, 2014
Teas/Email Correspondence Entered
Nov 24, 2014
Correspondence Received In Law Office
Nov 24, 2014
Teas Response To Office Action Received
Nov 1, 2014
Notification Of Non-Final Action E-Mailed
Nov 1, 2014
Non-Final Action E-Mailed
Nov 1, 2014
Non-Final Action Written
Oct 30, 2014
Assigned To Examiner
Sep 18, 2014
New Application Office Supplied Data Entered In Tram
Sep 13, 2014
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
